Sangamo Therapeutics Inc at Jefferies Healthcare Conference Transcript
My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'd like to introduce Sandy Macrae, the CEO of Sangamo. Thanks so much for joining us today, Sandy.
A pleasure to be with you.
And for those who may be new to the story, can you provide a 1-minute intro, highlighting your main products and key catalysts.
Delighted to do so. So we have compelling story of clinical products and a remarkable future to come. We're going to talk, I'm sure, about our 3 clinical phase assets, which are either in Phase III or about to go into Phase III in the coming year. We have fabry disease wholly owned with really interesting data that I think is a leading
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
